JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) ›› 2020, Vol. 40 ›› Issue (08): 1108-1112.doi: 10.3969/j.issn.1674-8115.2020.08.018

• Original article (Clinical research) • Previous Articles     Next Articles

Clinical characteristics and genetic analysis of adult late-onset glycogen storage disease type II

ZU Juan*, QIAN Fang-yuan*, WU Di, XIE Xin-xin, REN Qing-guo, ZHANG Zhi-jun   

  1. Department of Neurology, Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, China
  • Online:2020-08-28 Published:2020-08-28
  • Supported by:
    Medical Outstanding Scholars Foundation of Jiangsu Province of China (JCRCA2016006).

Abstract: Objective · To investigate the clinical and genetic characteristics of adult late-onset glycogen storage disease type Ⅱ (GSD Ⅱ). Methods · The clinical data, muscular magnetic resonance imaging (MRI) and muscle pathological characteristics of a patient with late-onset GSD Ⅱ were retrospectively analyzed and his family history was investigated. Peripheral blood DNAs of the proband and his father were extracted for genetic testing. Results · The proband presented progressive limb weakness for 7 years and short of breath after activities for 2 years. His parents were inbred, but he was the only one among the 18 members of 5 generations who had clinical phenotype. The blood creatine kinase moderately increased. The muscle MRI of both lower limbs showed that muscles were severely atrophied, and the fat component increased significantly. The pathological findings of muscle biopsy indicated vacuolar degeneration and increased activity of acid phosphatase. Gene sequencing confirmed that the pathogenicity was a homozygous mutation of acid α-glucosidase (GAA) gene c.1634C>T, and his father was a heterozygous mutation of c.1634C>T. Conclusion · Homozygous mutations of GAA gene c.1634C>T may lead to late-onset GSD Ⅱ .

Key words: late-onset glycogen storage disease type Ⅱ (GSD Ⅱ), genotype, clinical characteristic

CLC Number: